## ALLE: Allegion plc - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -5.3% below STRENGTH zone (4.0-10.0%); PEG 2.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($151.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Allegion increases revolving credit facility to $1 billion and extends maturity**
- Source: Investing.com | 20251209T210911 | Bullish | Relevance: 99%
-  Allegion plc announced it has increased its revolving credit facility from $750 million to $1 billion and extended its maturity to May 20, 2030. The company also borrowed $197.2 million under the facility to repay an outstanding term loan, resulting in no change to its total debt. This follows a strong Q3 2025 financial performance with revenue exceeding $1 billion and a raised full-year EPS outlook.

**2. Invesco Ltd. Reduces Stock Holdings in Allegion PLC $ALLE**
- Source: MarketBeat | 20251208T111954 | Neutral | Relevance: 99%
-  Invesco Ltd. has decreased its stake in Allegion PLC by 6.2% during the second quarter, selling 95,000 shares and reducing its total ownership to 1,427,784 shares, valued at $205,772,000. Despite this, other institutional investors like AQR Capital Management LLC and Kayne Anderson Rudnick Investment Management LLC have significantly increased their holdings in Allegion, with analyst ratings generally holding a "Hold" consensus for the stock. Allegion PLC reported strong third-quarter earnings, beating analyst estimates, and announced a quarterly dividend of $0.51 per share.

**3. Allegion (NYSE: ALLE) boosts $1.0B revolving credit facility and refinances term loan**
- Source: Stock Titan | 20251209T210726 | Neutral | Relevance: 98%
-  Allegion plc has expanded its revolving credit facility from $750 million to $1.0 billion and extended its maturity to May 20, 2030. The company also refinanced an outstanding term loan by borrowing $197.2 million under the new revolver, resulting in no change to its total debt. This move aims to enhance liquidity and streamline Allegion's borrowing structure.

**4. Allegion increases revolving credit facility to $1 billion and extends maturity By Investing.com**
- Source: Investing.com India | 20251209T220745 | Bullish | Relevance: 97%
-  Allegion plc announced an amendment to its credit agreement, increasing its revolving credit facility from $750 million to $1 billion and extending the maturity date to May 20, 2030. The company borrowed $197.2 million under the new facility to repay an outstanding term loan, resulting in no change to its total debt. This move follows a strong third quarter in 2025 where Allegion reported over $1 billion in revenue and raised its full-year EPS outlook.

**5. Allegion PLC $ALLE Shares Bought by Amundi**
- Source: MarketBeat | 20251209T080818 | Bullish | Relevance: 97%
-  Amundi significantly increased its stake in Allegion PLC by 30.4% in the second quarter, now holding 588,213 shares valued at approximately $87.03 million. Allegion exceeded Q2 earnings expectations with $2.30 EPS and $1.07 billion revenue, providing strong FY2025 guidance. The company also declared a quarterly dividend of $0.51, and its stock currently trades within a one-year range of $116.57–$180.68.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (-1.0%)
- Blackrock Inc.: 8.6% (-13.5%)
- Boston Partners: 5.5% (+1.0%)
- Kayne Anderson Rudni: 5.1% (-2.3%)
- State Street Corpora: 4.9% (+6.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.4% 5d) with bearish MACD, trend may be turning.
2. Near-term weakness: 6.6% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.00 elevated, pricing in significant growth expectations. Forward P/E 17.7x stretched relative to 9% growth. Quality metrics strong (ROE 36%, ROA 10%, margin 16%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.5B |
| Beta | 1.04 |
| 52W Range | $116.57 - $180.68 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.00 |
| Forward P/E | 17.7 |
| Current P/E | 19.2 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.0% to -5.3% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.3pp (needs >4.0% for momentum thesis). AM_20 at -3.2% indicates price below own 20MA trend. Underperforming sector by 3.8pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). Elevated volume (1.4x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.33% (CS: 15) | Weak |
| RSI_14 | 32.4 | Neutral |
| MACD Histogram | -0.30 | Bearish |
| vs SMA20 | 0.968x | Below |
| vs SMA50 | 0.934x | Below |
| vs SMA200 | 1.033x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $157.49
- **Stop Loss:** $151.21 (4.0% risk)
- **Target:** $163.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $12,441.71
- **Portfolio %:** 12.44%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-17 (Est: $1.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.24 | $2.30 | +2.5% |
| 2025Q2 | $1.99 | $2.04 | +2.7% |
| 2025Q1 | $1.67 | $1.86 | +11.2% |
| 2024Q4 | $1.75 | $1.86 | +6.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*